The firm said overall it remains on track for a previously described transformation and new instrument launches.
Bio-Rad Q4 Revenues Flat, Miss Analyst Estimates
The firm also said it is carrying excess inventory needed to assemble instruments and components that it acquired to fend off supply chain issues.
JP Morgan Healthcare Conference, Day 3: Invitae, Bio-Rad, Bio-Techne, Opko
On the penultimate day of the conference, Invitae provided color on its recent decisions to pull out of certain businesses, while Bio-Rad talked about its clinical plans.
Top Five Articles on 360Dx Last Week: FDA Clearances; Siemens' Diagnostics Plans; and More
Last week, readers were most interested in the diagnostic tests and platforms that were 510(k) cleared by the FDA last month.
Bio-Rad Laboratories, NuProbe USA Ink Licensing and Development Agreement
NuProbe will exclusively license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays.